We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$5.3M
Turnover
85.61%
1-Year Est. Return
7.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.09%
1 Year Est. Return
+7.8%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.86M
AUM Growth
-$188M
(-95%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-1,882.29%
Top 10 Holdings %
Top 10 Hldgs %
17.98%
Holding
708
New
41
Increased
5
Reduced
51
Closed
611
Avg Time Held
0.3
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACV Auctions
ACVA
|
+$194K |
| 2 |
Rapid7
RPD
|
+$183K |
| 3 |
Ellington Financial
EFC
|
+$181K |
| 4 |
Banco Santander
SAN
|
+$159K |
| 5 |
Oscar Health
OSCR
|
+$155K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXL Service
EXLS
|
+$830K |
| 2 |
Delek US
DK
|
+$724K |
| 3 |
Broadcom
AVGO
|
+$669K |
| 4 |
Itron
ITRI
|
+$666K |
| 5 |
Brinker International
EAT
|
+$649K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.83% |
| 2 | Technology | 15.87% |
| 3 | Healthcare | 10.98% |
| 4 | Industrials | 10.86% |
| 5 | Real Estate | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
KRONOS Worldwide
KRO
$855M
| $68.6K | 0.7% |
+10,448
| New | +$59.3K |
2026 Q1
0 quarters
|
|
77
Rimini Street
RMNI
$374M
| $68K | 0.69% |
+20,720
| New | +$71.9K |
2026 Q1
0 quarters
|
|
78
Community Health Systems
CYH
$406M
| $66.7K | 0.68% |
+22,699
| New | +$73.5K |
2026 Q1
0 quarters
|
|
79
Holley
HLLY
$302M
| $65.6K | 0.67% |
+21,381
| New | +$81K |
2026 Q1
0 quarters
|
|
80
Sweetgreen
SG
$1.2B
| $61.4K | 0.62% |
+11,827
| New | +$71.9K |
2026 Q1
0 quarters
|
|
81
Smart Sand
SND
$215M
| $59.7K | 0.61% |
+11,664
| New | +$52.6K |
2026 Q1
0 quarters
|
|
82
Telos
TLS
$300M
| $58.1K | 0.59% |
13,871
-88,693
| -86% | -$419K |
2025 Q4
1 quarter
|
|
83
MiMedx Group
MDXG
$646M
| $55.1K | 0.56% |
13,955
-30,303
| -68% | -$153K |
2025 Q3
2 quarters
|
|
84
Thryv Holdings
THRY
$53.8M
| $54.1K | 0.55% |
19,747
+8,506
| +76% | +$33.4K |
2025 Q3
2 quarters
|
|
85
Ardagh Metal Packaging
AMBP
$2.8B
| $53.6K | 0.54% |
13,225
-31,894
| -71% | -$141K |
2025 Q3
2 quarters
|
|
86
ReNew
RNW
$2.51B
| $52.9K | 0.54% |
11,557
-1,043
| -8% | -$5.55K |
2025 Q3
2 quarters
|
|
87
Real REMAX Group Inc. Common Stock
REAX
$347M
| $52.5K | 0.53% |
2,099
-7,749
| -79% | -$234K |
2025 Q3
2 quarters
|
|
88
Similarweb
SMWB
$737M
| $49.4K | 0.5% |
18,927
-16,757
| -47% | -$69.9K |
2025 Q4
1 quarter
|
|
|
UROY
89
Uranium Royalty Corp
UROY
$1.35B
| $46K | 0.47% |
+12,612
| New | +$51.5K |
2026 Q1
0 quarters
|
|
90
Imperial Petroleum
IMPP
$221M
| $44.5K | 0.45% |
10,392
-20,484
| -66% | -$81.8K |
2025 Q4
1 quarter
|
|
91
CuriosityStream
CURI
$155M
| $44.1K | 0.45% |
14,883
-91,189
| -86% | -$308K |
2025 Q3
2 quarters
|
|
92
Information Services Group
III
$274M
| $43.5K | 0.44% |
+11,322
| New | +$55.7K |
2026 Q1
0 quarters
|
|
93
Brandywine Realty Trust
BDN
$453M
| $43K | 0.44% |
15,878
-50,647
| -76% | -$152K |
2025 Q3
2 quarters
|
|
94
Newell Brands
NWL
$2.41B
| $43K | 0.44% |
12,538
-84,947
| -87% | -$357K |
2025 Q3
2 quarters
|
|
95
Petco
WOOF
$667M
| $40.5K | 0.41% |
14,575
-32,507
| -69% | -$89.9K |
2025 Q3
2 quarters
|
|
96
Agora
API
$368M
| $38.6K | 0.39% |
10,898
-64,783
| -86% | -$275K |
2025 Q3
2 quarters
|
|
97
Repay Holdings
RPAY
$334M
| $38.5K | 0.39% |
+14,814
| New | +$47.4K |
2026 Q1
0 quarters
|
|
98
Agilent Technologies
A
$48.8B
| – | – |
-4,524
| Closed | -$616K | – |
|
99
AbbVie
ABBV
$504B
| – | – |
-2,019
| Closed | -$461K | – |
|
100
ABM Industries
ABM
$3B
| – | – |
-9,557
| Closed | -$404K | – |
|
Similar funds
SA
BP
WI
PFGWM
BM
OFC
AL
WH
PharVision Advisers's Q1 2026 Portfolio in Review
As of Q1 2026, PharVision Advisers held 708 positions worth $9.86M, down 95% from $198M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
PharVision Advisers withdrew a net $186M in Q1 2026, closing 611 positions and reducing 51 holdings. Its most notable exit was EXL Service, an estimated $830K position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
Against the trend, PharVision Advisers opened a new position in ACV Auctions worth $125K.
- PharVision Advisers's largest Q1 2026 buy was ACV Auctions: 29,579 shares worth $125K.
- PharVision Advisers added most to Embecta in Q1 2026, an estimated $48.4K increase.
- PharVision Advisers's biggest Q1 2026 reduction was Herbalife, cutting an estimated $621K.
- PharVision Advisers fully exited EXL Service in Q1 2026, selling an estimated $830K.
- PharVision Advisers's ten largest holdings make up 18% of its $9.86M portfolio in Q1 2026.
- PharVision Advisers opened 41 new positions and closed 611 in Q1 2026.
- PharVision Advisers's portfolio value fell 95% quarter-over-quarter to $9.86M.
Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.